KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Receivables - Other: 2017-2024

Historic Receivables - Other for Emergent BioSolutions (EBS) over the last 8 years, with Dec 2024 value amounting to $19.6 million.

  • Emergent BioSolutions' Receivables - Other rose 0.52% to $19.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.3 million, marking a year-over-year increase of 0.52%. This contributed to the annual value of $19.6 million for FY2024, which is 61.87% down from last year.
  • As of FY2024, Emergent BioSolutions' Receivables - Other stood at $19.6 million, which was down 61.87% from $51.4 million recorded in FY2023.
  • In the past 5 years, Emergent BioSolutions' Receivables - Other registered a high of $58.2 million during FY2020, and its lowest value of $19.6 million during FY2024.
  • Moreover, its 3-year median value for Receivables - Other was $51.4 million (2023), whereas its average is $42.7 million.
  • Per our database at Business Quant, Emergent BioSolutions' Receivables - Other spiked by 34.10% in 2020 and then tumbled by 61.87% in 2024.
  • Over the past 5 years, Emergent BioSolutions' Receivables - Other (Yearly) stood at $58.2 million in 2020, then declined by 11.34% to $51.6 million in 2021, then grew by 10.85% to $57.2 million in 2022, then decreased by 10.14% to $51.4 million in 2023, then crashed by 61.87% to $19.6 million in 2024.